Viewing StudyNCT04872985



Ignite Creation Date: 2024-05-06 @ 4:07 PM
Last Modification Date: 2024-10-26 @ 2:03 PM
Study NCT ID: NCT04872985
Status: RECRUITING
Last Update Posted: 2021-05-05
First Post: 2021-04-29

Brief Title: Pyrotinib in Combination With Neoadjuvant Chemotherapy in HRHER2- HER4 High Expression Breast Cancer Patients A Phase II Trial
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Conditions & Keywords Data

Conditions:
Name
Hormone-receptor Positive Breast Cancer
Breast Cancer
Keywords:
Name View
HER4 View
Pyrotinib View
Pan-HER TKI View